These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 31682728)

  • 1. Global and Specific Cortical Volume Asymmetries in Individuals With Psychosis Risk Syndrome and Schizophrenia: A Mixed Cross-sectional and Longitudinal Perspective.
    Damme KSF; Vargas T; Calhoun V; Turner J; Mittal VA
    Schizophr Bull; 2020 Apr; 46(3):713-721. PubMed ID: 31682728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical abnormalities in youth at clinical high-risk for psychosis: Findings from the NAPLS2 cohort.
    Chung Y; Allswede D; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; McEwen S; van Erp TGM; Cannon TD;
    Neuroimage Clin; 2019; 23():101862. PubMed ID: 31150956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis.
    ; Jalbrzikowski M; Hayes RA; Wood SJ; Nordholm D; Zhou JH; Fusar-Poli P; Uhlhaas PJ; Takahashi T; Sugranyes G; Kwak YB; Mathalon DH; Katagiri N; Hooker CI; Smigielski L; Colibazzi T; Via E; Tang J; Koike S; Rasser PE; Michel C; Lebedeva I; Hegelstad WTV; de la Fuente-Sandoval C; Waltz JA; Mizrahi R; Corcoran CM; Resch F; Tamnes CK; Haas SS; Lemmers-Jansen ILJ; Agartz I; Allen P; Amminger GP; Andreassen OA; Atkinson K; Bachman P; Baeza I; Baldwin H; Bartholomeusz CF; Borgwardt S; Catalano S; Chee MWL; Chen X; Cho KIK; Cooper RE; Cropley VL; Dolz M; Ebdrup BH; Fortea A; Glenthøj LB; Glenthøj BY; de Haan L; Hamilton HK; Harris MA; Haut KM; He Y; Heekeren K; Heinz A; Hubl D; Hwang WJ; Kaess M; Kasai K; Kim M; Kindler J; Klaunig MJ; Koppel A; Kristensen TD; Kwon JS; Lawrie SM; Lee J; León-Ortiz P; Lin A; Loewy RL; Ma X; McGorry P; McGuire P; Mizuno M; Møller P; Moncada-Habib T; Muñoz-Samons D; Nelson B; Nemoto T; Nordentoft M; Omelchenko MA; Oppedal K; Ouyang L; Pantelis C; Pariente JC; Raghava JM; Reyes-Madrigal F; Roach BJ; Røssberg JI; Rössler W; Salisbury DF; Sasabayashi D; Schall U; Schiffman J; Schlagenhauf F; Schmidt A; Sørensen ME; Suzuki M; Theodoridou A; Tomyshev AS; Tor J; Værnes TG; Velakoulis D; Venegoni GD; Vinogradov S; Wenneberg C; Westlye LT; Yamasue H; Yuan L; Yung AR; van Amelsvoort TAMJ; Turner JA; van Erp TGM; Thompson PM; Hernaus D
    JAMA Psychiatry; 2021 Jul; 78(7):753-766. PubMed ID: 33950164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical Thickness Abnormalities at Different Stages of the Illness Course in Schizophrenia: A Systematic Review and Meta-analysis.
    Zhao Y; Zhang Q; Shah C; Li Q; Sweeney JA; Li F; Gong Q
    JAMA Psychiatry; 2022 Jun; 79(6):560-570. PubMed ID: 35476125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Changes in Cortical Surface Area Associated With Transition to Psychosis in Adolescents at Clinical High Risk for the Disease.
    Fortea A; van Eijndhoven P; Ilzarbe D; Batalla A; Calvet-Mirabent A; de la Serna E; Puig O; Castro-Fornieles J; Dolz M; Tor J; Parrilla S; Via E; Stephan-Otto C; Baeza I; Sugranyes G
    J Am Acad Child Adolesc Psychiatry; 2023 May; 62(5):593-600. PubMed ID: 36638884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain structural abnormalities as potential markers for detecting individuals with ultra-high risk for psychosis: A systematic review and meta-analysis.
    Ding Y; Ou Y; Pan P; Shan X; Chen J; Liu F; Zhao J; Guo W
    Schizophr Res; 2019 Jul; 209():22-31. PubMed ID: 31104914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Striatal and Reduced Prefrontal Cerebral Blood Flow in Clinical High Risk for Psychosis.
    Kindler J; Schultze-Lutter F; Hauf M; Dierks T; Federspiel A; Walther S; Schimmelmann BG; Hubl D
    Schizophr Bull; 2018 Jan; 44(1):182-192. PubMed ID: 28575528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prefrontal cortical dopamine release in clinical high risk for psychosis during a cognitive task: a [
    Tagore A; Schifani C; Rao N; Tseng HH; Zakzanis KK; Rusjan PM; Houle S; Mizrahi R
    Eur Neuropsychopharmacol; 2019 Sep; 29(9):1023-1032. PubMed ID: 31351843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline Cortical Thickness Reductions in Clinical High Risk for Psychosis: Brain Regions Associated with Conversion to Psychosis Versus Non-Conversion as Assessed at One-Year Follow-Up in the Shanghai-At-Risk-for-Psychosis (SHARP) Study.
    Del Re EC; Stone WS; Bouix S; Seitz J; Zeng V; Guliano A; Somes N; Zhang T; Reid B; Lyall A; Lyons M; Li H; Whitfield-Gabrieli S; Keshavan M; Seidman LJ; McCarley RW; Wang J; Tang Y; Shenton ME; Niznikiewicz MA
    Schizophr Bull; 2021 Mar; 47(2):562-574. PubMed ID: 32926141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain network characteristics separating individuals at clinical high risk for psychosis into normality or psychosis.
    Choi SH; Kyeong S; Cho KIK; Yun JY; Lee TY; Park HY; Kim SN; Kwon JS
    Schizophr Res; 2017 Dec; 190():107-114. PubMed ID: 28325573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired Prefrontal Cortical Dopamine Release in Schizophrenia During a Cognitive Task: A [11C]FLB 457 Positron Emission Tomography Study.
    Rao N; Northoff G; Tagore A; Rusjan P; Kenk M; Wilson A; Houle S; Strafella A; Remington G; Mizrahi R
    Schizophr Bull; 2019 Apr; 45(3):670-679. PubMed ID: 29878197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related change in cortical thickness in adolescents at clinical high risk for psychosis: a longitudinal study.
    Fortea A; van Eijndhoven P; Calvet-Mirabent A; Ilzarbe D; Batalla A; de la Serna E; Puig O; Castro-Fornieles J; Dolz M; Tor J; Parrilla S; Via E; Stephan-Otto C; Baeza I; Sugranyes G
    Eur Child Adolesc Psychiatry; 2024 Jun; 33(6):1837-1846. PubMed ID: 37644217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk.
    Chung Y; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; McEwen S; van Erp TGM; Cannon TD;
    JAMA Psychiatry; 2018 Sep; 75(9):960-968. PubMed ID: 29971330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered Thalamo-Cortical White Matter Connectivity: Probabilistic Tractography Study in Clinical-High Risk for Psychosis and First-Episode Psychosis.
    Cho KI; Shenton ME; Kubicki M; Jung WH; Lee TY; Yun JY; Kim SN; Kwon JS
    Schizophr Bull; 2016 May; 42(3):723-31. PubMed ID: 26598740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-onset sub-threshold psychotic symptoms and cortical organization in the first episode of psychosis.
    Rosengard RJ; Makowski C; Chakravarty M; Malla AK; Joober R; Shah JL; Lepage M
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jun; 100():109879. PubMed ID: 32004638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying functional network changing patterns in individuals at clinical high-risk for psychosis and patients with early illness schizophrenia: A group ICA study.
    Du Y; Fryer SL; Lin D; Sui J; Yu Q; Chen J; Stuart B; Loewy RL; Calhoun VD; Mathalon DH
    Neuroimage Clin; 2018; 17():335-346. PubMed ID: 29159045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosis.
    Chung Y; Haut KM; He G; van Erp TGM; McEwen S; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; Cannon TD;
    Schizophr Res; 2017 Nov; 189():169-174. PubMed ID: 28245961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should I Stay or Should I Go? FMRI Study of Response Inhibition in Early Illness Schizophrenia and Risk for Psychosis.
    Fryer SL; Roach BJ; Ford JM; Donaldson KR; Calhoun VD; Pearlson GD; Kiehl KA; Srihari VH; McGlashan TH; Woods SW; Mathalon DH
    Schizophr Bull; 2019 Jan; 45(1):158-168. PubMed ID: 29385625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperactivity of caudate, parahippocampal, and prefrontal regions during working memory in never-medicated persons at clinical high-risk for psychosis.
    Thermenos HW; Juelich RJ; DiChiara SR; Mesholam-Gately RI; Woodberry KA; Wojcik J; Makris N; Keshavan MS; Whitfield-Gabrieli S; Woo TU; Petryshen TL; Goldstein JM; Shenton ME; McCarley RW; Seidman LJ
    Schizophr Res; 2016 May; 173(1-2):1-12. PubMed ID: 26965745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain Age Gap in Early Illness Schizophrenia and the Clinical High-Risk Syndrome: Associations With Experiential Negative Symptoms and Conversion to Psychosis.
    Hua JPY; Abram SV; Loewy RL; Stuart B; Fryer SL; Vinogradov S; Mathalon DH
    Schizophr Bull; 2024 Aug; 50(5):1159-1170. PubMed ID: 38815987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.